BioSpace News Archive

Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product, SofPulse® by the Taiwan Food and Drug Administration (TFDA), the regulatory division of the Ministry of Health and Welfare (MOHW).

Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the publication of clinical data in Interventional Neuroradiology (INR) of the Zoom Aspiration Catheters in patients with large and medium vessel occlusions.

Anaconda Biomed S.L. has announced that the European Patent Office has granted the company a European patent for “A Device and a Thrombectomy Apparatus for Extraction of Thrombus from a Blood Vessel,” published as Patent No. EP3866708 B1 on September 27, 2023.

Mission Bio announced data underscoring the ability of the Tapestri® Platform to potentially impact cancer therapy by correlating cell surface protein expression of potential therapeutic targets with multiple myeloma (MM) clonal populations.

BioAtla, Inc. announced that Jay M. Short, Ph.D., Chairman, Chief Executive Officer and Cofounder, has been chosen by The Explorers Club as a recipient of this year’s Lowell Thomas Award.

Windtree Therapeutics, Inc. today announced that Craig Fraser, President and Chief Executive Officer, will be presenting at the upcoming ThinkEquity Conference on Thursday, October 19, 2023 at 4:30pm ET.

Theratechnologies Inc. today announced dosing of the first participant in Part 3 of its Phase 1 clinical trial of sudocetaxel zendusortide in patients with advanced ovarian cancer.

Leading supply chain visibility provider FourKites today announced that Teva, a global leader in generic and innovative medicines, has achieved a 0.005% incident rate by leveraging FourKites’ global carrier visibility solution, NIC-Place.

Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2023 financial results on Thursday, Nov. 2, after market close.

Ocean Biomedical, Inc. and Virion Therapeutics, LLC announced they have entered into a joint venture to accelerate and expand Virion’s clinical-stage program and pipeline, with the goal of finding cures for patients with cancer and chronic infectious diseases.